Blockchain Registration Transaction Record

Vivos Therapeutics CEO Announces Medicare Approval for Unique Sleep Apnea Treatment Devices

Vivos Therapeutics CEO announces FDA clearance for oral medical devices designed to treat sleep apnea, offering a unique alternative to CPAP treatments and potentially transforming patient care.

<p>The approval for Medicare reimbursement for Vivos's oral medical devices is significant as it provides a new alternative for millions of Medicare patients suffering from sleep apnea. This development has the potential to transform patient care for individuals with sleep apnea, offering a unique and effective treatment option. With recent recalls in the CPAP market, Vivos's FDA clearance comes at a crucial time, providing hope for improved patient care and treatment.</p>